LEONARD REYNO

Insider Reports History

Location
Los Angeles, CA
Signature
/s/ Shagha Russell, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by LEONARD REYNO:

Company Role Class Num Shares Value Price $ Report Date Ownership
C4 Therapeutics, Inc. Chief Medical Officer Common Stock 156,382 $347,168 $2.22 16 Jan 2026 Direct
C4 Therapeutics, Inc. Chief Medical Officer Stock Option (Right to Buy) 130,600 14 Feb 2025 Direct

Insider Reports Filed by LEONARD REYNO

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CCCC C4 Therapeutics, Inc. 16 Jan 2026 1 -$22,200 4 Chief Medical Officer 16 Jan 2026, 16:27
CCCC C4 Therapeutics, Inc. 10 Jul 2025 2 -$14,690 4/A Chief Medical Officer 15 Jul 2025, 09:00
CCCC C4 Therapeutics, Inc. 14 Feb 2025 3 -$16,361 4 Chief Medical Officer 18 Feb 2025, 16:54
CCCC C4 Therapeutics, Inc. 10 Jul 2024 1 -$30,955 4 Chief Medical Officer 11 Jul 2024, 16:16
CCCC C4 Therapeutics, Inc. 14 Feb 2024 2 $0 4 Chief Medical Officer 15 Feb 2024, 17:08
CCCC C4 Therapeutics, Inc. 10 Jul 2023 2 $0 4 Chief Medical Officer 12 Jul 2023, 16:06
CCCC C4 Therapeutics, Inc. 10 Jul 2023 0 $0 3 Chief Medical Officer 12 Jul 2023, 16:05